Harmonizing allergy care-integrated care pathways and multidisciplinary approaches.
Allergy
Healthcare
Integrated care pathways
Multidisciplinary team
Journal
The World Allergy Organization journal
ISSN: 1939-4551
Titre abrégé: World Allergy Organ J
Pays: United States
ID NLM: 101481283
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
01
02
2021
revised:
08
08
2021
accepted:
26
08
2021
entrez:
25
11
2021
pubmed:
26
11
2021
medline:
26
11
2021
Statut:
epublish
Résumé
There is a wide time gap between the publication of evidence and the application of new knowledge into routine clinical practice. The consequence is sub-optimal outcomes, particularly concerning for long-term relapsing/remitting conditions such as allergic diseases. In response, there has been a proliferation of published guidelines which systematically review evidence for the gold-standard management of most allergic disorders. However, this has not necessarily been followed by improved outcomes, partly due to a lack of coordination across the patient pathway. This has become known as the "second translational gap". A proposed solution is the development and implementation of integrated care pathways (ICPs) to optimize patient outcomes, with the notion that evidence-based medicine requires evidence-based implementation. ICP implementation is shown to improve short-term outcomes for acute conditions and routine surgery, including reduced length of hospital stay, improved documentation and improved patient safety. However, this improvement is not reflected in patient experience or patient-centered functional outcomes. The implementation of life-long, cost-effective interventions within comprehensive pathways requires a deep appreciation for complexity within allergy care. We promote an evidence-based methodology for the implementation of ICPs for allergic disorders in which all stakeholders in allergy care are positioned equally and encouraged to contribute, particularly patients and their caregivers. This evidence-based process commences with scoping the unmet needs, followed by stakeholder mapping. All stakeholders are invited to meetings to develop a common vision and mission through the generation of action/effect diagrams which helps build concordance across the agencies. Dividing the interventions into achievable steps and reviewing with plan/do/study/act cycles will gradually modify the pathway to achieve the best outcomes. While the management guidelines provide the core knowledge, the key component of implementation involves education, training, and support of all healthcare professionals (HCPs), patients and their caregivers. The pathways should define the level of competence required for each clinical task. It may be useful to leave the setting of care delivery or the specific HCP involved undefined to account for variable patterns of health service delivery as well as local socioeconomic, ethnic, environmental, and political imperatives. In all cases, where competence is exceeded, it is necessary to refer to the next stage in the pathway. The success and sustainability of ICPs would ideally be judged by patient experience, health outcomes, and health economics. We provide examples of successful programs, most notably from Finland, but recommend that further research is required in diverse settings to optimize outcomes worldwide.
Identifiants
pubmed: 34820045
doi: 10.1016/j.waojou.2021.100584
pii: S1939-4551(21)00078-8
pmc: PMC8591185
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100584Informations de copyright
© 2021 Published by Elsevier Inc. on behalf of World Allergy Organization.
Références
JAMA Pediatr. 2013 Nov;167(11):1026-31
pubmed: 24042236
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006632
pubmed: 20238347
Clin Transl Allergy. 2018 Aug 21;8:31
pubmed: 30151118
Allergy Asthma Clin Immunol. 2020 Mar 18;16:20
pubmed: 32206067
Allergy. 2013 Oct;68(10):1211-8
pubmed: 24053537
NPJ Prim Care Respir Med. 2019 Apr 2;29(1):9
pubmed: 30940806
Pediatr Allergy Immunol. 2011 Nov;22(7):742-50
pubmed: 21950680
BMJ Open. 2017 Jul 20;7(7):e015901
pubmed: 28729318
NPJ Prim Care Respir Med. 2017 Aug 11;27(1):48
pubmed: 28801654
Clin Exp Allergy. 2021 Jan;51(1):6-8
pubmed: 33386687
Br J Dermatol. 2003 Sep;149(3):582-9
pubmed: 14510993
BMJ Qual Saf. 2014 Dec;23(12):1040-8
pubmed: 25319412
Hong Kong Med J. 2015 Feb;21(1):52-60
pubmed: 25554794
Nutrients. 2017 Aug 09;9(8):
pubmed: 28792480
Ann Allergy Asthma Immunol. 2015 Jan;114(1):23-9
pubmed: 25454014
J Allergy Clin Immunol Pract. 2020 Jan;8(1):75-90.e17
pubmed: 31950914
J Thorac Dis. 2019 Sep;11(9):4072-4084
pubmed: 31656683
BMJ Qual Saf. 2017 Mar;26(3):248-251
pubmed: 27001867
J Allergy Clin Immunol Pract. 2017 Mar - Apr;5(2):312-324.e29
pubmed: 28283156
Thorax. 2006 Aug;61(8):663-70
pubmed: 16877690
Br J Gen Pract. 2019 Aug;69(685):405-406
pubmed: 31345822
Allergy. 2013 Jul;68(7):836-43
pubmed: 23735183
J Allergy Clin Immunol Pract. 2017 Mar - Apr;5(2):352-357.e1
pubmed: 27888035
BMJ. 1996 Jan 13;312(7023):71-2
pubmed: 8555924
Int Arch Allergy Immunol. 2006;139(2):166-74
pubmed: 16388197
Clin Exp Allergy. 2019 Dec;49(12):1534-1540
pubmed: 31518446
J Am Pharm Assoc (2003). 2016 Nov - Dec;56(6):665-669
pubmed: 27745795
Pediatr Allergy Immunol. 2015 Mar;26(2):126-32
pubmed: 25616166
Allergy. 2008 Apr;63 Suppl 86:8-160
pubmed: 18331513
J Allergy Clin Immunol Pract. 2015 Jan-Feb;3(1):13-23; quiz 24
pubmed: 25577613
J Allergy Clin Immunol. 2010 Dec;126(6 Suppl):S1-58
pubmed: 21134576
Allergy Asthma Proc. 2018 Nov 16;39(6):430-436
pubmed: 30326990
BMJ Qual Saf. 2014 Apr;23(4):290-8
pubmed: 24025320
J Allergy Clin Immunol Pract. 2021 Jan;9(1):44-56.e1
pubmed: 33127520
J Allergy Clin Immunol. 2017 Oct;140(4):950-958
pubmed: 28602936
Prim Care Respir J. 2007 Oct;16(5):284-90
pubmed: 17906825
Clin Exp Allergy. 2018 Feb;48(2):121-137
pubmed: 29315948
BMC Nurs. 2020 Nov 4;19(1):102
pubmed: 33292229
J Asthma. 2014 Jun;51(5):480-92
pubmed: 24471514
BMC Med. 2017 Mar 17;15(1):64
pubmed: 28302126
Allergy. 2019 Jul;74(7):1219-1236
pubmed: 30565275
J Allergy Clin Immunol. 2019 Mar;143(3):813-828
pubmed: 30850069
J Manag Care Spec Pharm. 2018 Nov;24(11):1184-1196
pubmed: 30362920
J R Soc Med. 2011 Dec;104(12):501-9
pubmed: 22179293
Clin Exp Allergy. 2012 Feb;42(2):284-92
pubmed: 22181034
Ann Allergy Asthma Immunol. 2016 Mar;116(3):230-236.e1
pubmed: 26851890
Arch Dis Child. 2016 Oct;101(10):935-43
pubmed: 27484970
Am J Med. 2014 Jan;127(1 Suppl):S1-5
pubmed: 24384132
BMJ Open. 2017 Feb 7;7(2):e012647
pubmed: 28174222
Eur Respir J. 2018 Aug 23;52(2):
pubmed: 29976652
Int Arch Allergy Immunol. 2015;167(1):57-64
pubmed: 26184344
J Allergy Clin Immunol. 2010 Sep;126(3):466-76
pubmed: 20816182
Clin Transl Allergy. 2019 Jan 24;9:3
pubmed: 30697418
Health Soc Care Community. 2004 Nov;12(6):527-36
pubmed: 15717899
Clin Transl Allergy. 2015 Feb 19;5:7
pubmed: 25741437
JAMA Netw Open. 2020 Aug 3;3(8):e2013070
pubmed: 32804213
Clin Ther. 2017 Dec;39(12):2410-2419
pubmed: 29079387
J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):383-399
pubmed: 29109046
Prim Care Respir J. 2005 Aug;14(4):204-9
pubmed: 16701726
J Allergy Clin Immunol Pract. 2020 Jun;8(6):2107-2109.e3
pubmed: 32112925
Allergy. 2013 Nov;68(11):1362-9
pubmed: 24117436
Ann Allergy Asthma Immunol. 2013 Nov;111(5):415-419.e1
pubmed: 24125151
BMJ Open. 2013 Jan 03;3(1):
pubmed: 23293244
J R Soc Med. 2010 Nov;103(11):430-1
pubmed: 21037330
Pediatrics. 2016 May;137(5):
pubmed: 27244806
Int Arch Allergy Immunol. 2014;163(2):106-13
pubmed: 24296744
Allergy Asthma Proc. 2017 Mar 1;38(2):88-91
pubmed: 28234046
J Allergy Clin Immunol Pract. 2021 Jan;9(1):101-108
pubmed: 33429704
Thorax. 2011 Dec;66(12):1025-6
pubmed: 21948729
BMC Med Inform Decis Mak. 2014 Sep 09;14:82
pubmed: 25204381
Clin Exp Allergy. 2018 Sep;48(9):1195-1205
pubmed: 29900599
Ann Allergy Asthma Immunol. 2019 Apr;122(4):373-380.e1
pubmed: 30703439
J Korean Med Sci. 2020 Mar 30;35(12):e72
pubmed: 32233156